Evaluation of oxidant and intracellular anti-oxidant activity in rheumatoid arthritis patients: In vivo and in silico studies.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 11 12 2020
revised: 20 03 2021
accepted: 03 04 2021
pubmed: 26 4 2021
medline: 4 1 2022
entrez: 25 4 2021
Statut: ppublish

Résumé

Rheumatoid Arthritis (RA) is the most prevalent cause of the systematic inflammatory arthritis that destroys the joints. While the pathogenesis of RA remains to be clarified, the imbalance in the oxidant and anti-oxidant defense system plays a crucial role. This study aims to evaluate oxidant and anti-oxidant levels of RA patients and their impacts on the activity of the disease via in silico studies. 28 patients who had not previously received any treatment for RA and 20 healthy controls were included. Their oxidative stress markers, antioxidant markers, and inflammatory factors were investigated via in silico studies. Compared to the Control Group, serum CRP levels, MDA levels, and XO activities were higher in RA Group. Cu/ZnSOD and GPx activities decreased while CAT activities remained unchanged. Besides, there was a positive correlation between MDA-serum CRP levels but a negative correlation between MDA levels-Cu/ZnSOD activities. Furthermore, we observed a negative correlation between CRP levels and Cu/ZnSOD activities. Based on these results, it was concluded that oxidative stress had increased, the defense system had weakened, and ROS production had increased. Finally, our study results with SOD and CAT activity were confirmed by molecular docking studies.

Identifiants

pubmed: 33895477
pii: S1567-5769(21)00290-3
doi: 10.1016/j.intimp.2021.107654
pii:
doi:

Substances chimiques

Antioxidants 0
Oxidants 0
Reactive Oxygen Species 0
Malondialdehyde 4Y8F71G49Q
C-Reactive Protein 9007-41-4
CAT protein, human EC 1.11.1.6
Catalase EC 1.11.1.6
Superoxide Dismutase EC 1.15.1.1

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

107654

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Yasemin Oğul (Y)

Department of Medicinal Biochemistry, Regional Training and Research Hospital, Health Sciences University, 25240 Erzurum, Turkey. Electronic address: dryogul7@gmail.com.

Fatma Gür (F)

Department of Medical Services and Techniques, Health Services Vocational School, Ataturk University, 25240 Erzurum, Turkey.

Mustafa Cengiz (M)

Department of Elementary Education, Faculty of Education, Siirt University, 56100 Siirt, Turkey.

Bahri Gür (B)

Department of Biochemistry, Faculty of Sciences and Arts, Iğdır University, 76000 Iğdır, Turkey.

Refik Ali Sarı (RA)

Department of Internal Diseases, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey.

Ahmet Kızıltunç (A)

Department of Biochemistry, Faculty of Medicine, Ataturk University, 25240 Erzurum, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH